scholarly journals Rapid and Dramatic Radiographic and Clinical Response to an ALK Inhibitor (Crizotinib, PF02341066) in an ALK Translocation-Positive Patient with Non-small Cell Lung Cancer

2010 ◽  
Vol 5 (12) ◽  
pp. 2044-2046 ◽  
Author(s):  
Sai-Hong Ignatius Ou ◽  
Lyudmila Bazhenova ◽  
D. Ross Camidge ◽  
Benjamin J. Solomon ◽  
June Herman ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Clinical Response ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Positive Patient ◽  
Small Cell Lung ◽  
Alk Inhibitor

scholarly journals Identification of a potent kinase inhibitor targeting EML4-ALK fusion protein in non-small cell lung cancer

MedChemComm ◽  
2017 ◽  
Vol 8 (10) ◽  
pp. 1914-1918
Author(s):  
Lian-Xiang Luo ◽  
Ying Li ◽  
Yu-Zhen Niu ◽  
Yu-Wei Wang ◽  
Qian-Qian Wang ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Fusion Protein ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Kinase Inhibitor ◽  
Small Cell ◽  
Small Cell Lung ◽  
Lung Cancers ◽  
Alk Inhibitor

Herein, we reported 5067-0952, a potent ALK inhibitor with pharmacological efficacy in non-small cell lung cancers harboring the ALK fusion oncogene.

Histopathological and immunohistochemical features associated with clinical response to neoadjuvant gefitinib therapy in early stage non-small cell lung cancer

Lung Cancer ◽  
2012 ◽  
Vol 76 (2) ◽  
pp. 235-241 ◽  
Author(s):  
Humberto Lara-Guerra ◽  
Catherine T. Chung ◽  
Joerg Schwock ◽  
Melania Pintilie ◽  
David M. Hwang ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Clinical Response ◽  
Cell Lung Cancer ◽  
Early Stage ◽  
Small Cell ◽  
Small Cell Lung

Clinical Response to Etoposide Plus Carboplatin and Topotecan Chemotherapy in Small Cell Lung Cancer

2003 ◽  
Vol 54 (4) ◽  
pp. 415
Author(s):  
Kyung Hwa Park ◽  
Gye Jung Cho ◽  
Jin Young Ju ◽  
Chang Young Son ◽  
Jeong Ook Wi ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Clinical Response ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung

scholarly journals ALK Inhibitor PF02341066 (Crizotinib) Increases Sensitivity to Radiation in Non–Small Cell Lung Cancer Expressing EML4-ALK

2013 ◽  
Vol 12 (5) ◽  
pp. 696-704 ◽  
Author(s):  
Yunguang Sun ◽  
Kamila A. Nowak ◽  
Nicholas G. Zaorsky ◽  
Chia-Lin Winchester ◽  
Kunal Dalal ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Alk Inhibitor
Sign in / Sign up

Export Citation Format

Share Document